Impact of obesity on childhood kidney

Pediatric Reports

Volumn 3, Issue 4, 2011, Pages 108-110

  Kaneko, Kazunari ^a   Kimata, Takahisa ^a   Tsuji, Shoji ^a   Shiraishi, Kazumi ^b   Yamauchi, Kuniaki ^b   Murakami, Mutsumi ^b   Kitagawa, Teruo ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Tokyo Association of Health Service   (Japan)

Author keywords

Obesity index; Obesity related glomerulopathy; Overweight child; Urinary screening

Indexed keywords

EID: 84904306649     PISSN: None     EISSN: 20367503     Source Type: Journal    
DOI: 10.4081/pr.2011.e27     Document Type: Article

References (16)

1. Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-509.
2. Ross WR, McGill JB. Epidemiology of obesity and chronic kidney disease. Adv Chronic Kidney Dis 2006;13: 325-35.
3. Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr Nephrol 2006; 21:463-70.
4. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974;81:440-7.
5. Matsushita Y, Yoshiike N, Kaneda F, et al. Trends in childhood obesity in Japan over the last 25 years from the national nutrition survey. Obes Res 2004;12:205-14.
6. Murakami M, Yamamoto H, Ueda Y, et al. Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo. Pediatr Nephrol 1991; 5:50-3.
7. Speiser PW, Rudolf MC, Anhalt H, et al. Childhood obesity. J Clin Endocrinol Metab 2005;90:1871-87.
8. Troiano RP, Flegal KM, Kuczmarski RJ, et al. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 1995;149:1085-91.
9. Gilardini L, Parati G, Sartorio A, et al. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008;22:75-82.
10. Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42:878-84.
11. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obe-sity. Am J Physiol Renal Physiol 2000; 278:F817-22.
12. Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 1999;33:52-8.
13. Hall JE, Crook ED, Jones DW, et al. Mechanisms of obesity-associated cardio vascular and renal disease. Am J Med Sci 2002;324:127-37.
14. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002;26 Suppl4:S21-4.
15. Wu Y, Liu Z, Xiang Z, et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006;147:44-50.
16. Lamarca BD, Ryan MJ, Gilbert JS, et al. Inflammatory Cytokines in the Pathophysiology of Hypertension during Preeclampsia. Curr Hypertens Rep 2007; 9:480-5.